U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343089) titled 'A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France' on Jan. 06.
Brief Summary: Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.
Study Start Date: Aug. 29, 2025
Study Type: OBSERVATIONAL
Condition:
Borrelia Infections
Recruitment Status: RECRUITING
Sponsor: University Hospital, Strasbourg, France
Disclaimer: Curated by HT Syndication....